Literature DB >> 15964379

De novo hepatocellular carcinoma in a liver allograft associated with recurrent hepatitis B.

M Torbenson1, D Grover, J Boitnott, A Klein, E Molmenti.   

Abstract

Recurrent hepatocellular carcinoma is well described following liver transplantation. However, de novo hepatocellular carcinoma in the allograft is rare. We describe the clinical and pathological features of a case of de novo hepatocellular carcinoma arising in a cirrhotic allograft 9 years following transplantation for chronic hepatitis B.

Entities:  

Mesh:

Year:  2005        PMID: 15964379     DOI: 10.1016/j.transproceed.2005.03.093

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Management of de novo hepatocellular carcinoma developing in a transplanted liver.

Authors:  Yoshiaki Kita; Katsuhiko Yanaga
Journal:  Dig Dis Sci       Date:  2007-12-13       Impact factor: 3.199

2.  De-novo hepatocellular carcinoma after pediatric living donor liver transplantation.

Authors:  Samuel Torres-Landa; Armando Salim Muñoz-Abraham; Brett E Fortune; Ananta Gurung; Jeffrey Pollak; Sukru H Emre; Manuel I Rodriguez-Davalos; Michael L Schilsky
Journal:  World J Hepatol       Date:  2017-12-28

3.  Intrahepatic De Novo Tumors in Liver Recipients are Highly Associated With Recurrent Viral Hepatitis.

Authors:  Michael J Pflüger; Max M Maurer; Karl H Hillebrandt; Andreas Andreou; Dominik Geisel; Moritz Schmelzle; Johann Pratschke; Dennis Eurich
Journal:  J Clin Exp Hepatol       Date:  2020-11-25

4.  A case report of de novo hepatocellular carcinoma after living donor liver transplantation.

Authors:  Songfeng Yu; Hua Guo; Li Zhuang; Jun Yu; Sheng Yan; Min Zhang; Weilin Wang; Shusen Zheng
Journal:  World J Surg Oncol       Date:  2013-08-06       Impact factor: 2.754

5.  De novo Hepatocellular Carcinoma after Liver Transplantation.

Authors:  Sammy Saab; Kali Zhou; Edward K Chang; Ronald W Busuttil
Journal:  J Clin Transl Hepatol       Date:  2015-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.